Satellite Banner
Technology Networks Header
Saturday, September 20, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
OriGene Launches Genome-wide Gene-knockout Kits Using CRISPR Platform
Thursday, May 08, 2014
A complete solution to knock out a human gene at the chromosomal level.

Dako Launches Two Ready-to-Use Antibodies for Cancer Diagnosis
Wednesday, May 07, 2014
Company announces addition of Anti-CK 8/18 and Anti-TdT antibodies for routine diagnostic use.

VolitionRx Announces First Published Data in Anticancer Research Journal
Wednesday, April 30, 2014
The preliminary data, which demonstrated high detection rates for colorectal cancer, was the first to be publicly shared by the company last year

OGT Launch Cancer Sequencing Panel at ACGS
Wednesday, April 30, 2014
Accurate solid tumour profiling for clinical and translational research

Enrichment of Highly Abundant Epigenetic Marks from Endometrial Stromal Cells
Wednesday, April 30, 2014
Chromatrap®, the novel solid-based matrix for chromatin immunoprecipitation (ChIP) assays, available from Porvair Sciences, has been successfully used to isolate high quality chromatin from difficult biopsy material.

Molecular Devices Introduces Microplate Reader and Washer
Monday, April 28, 2014
The inexpensive and versatile EMax® Plus Microplate Reader and MultiWash™+ Microplate Washer are designed for labs just starting up or looking to extend capabilities with affordable, yet reliable instrumentation that utilizes the industry-standard SoftMax® Pro Microplate Data Acquisition and Analysis Software.

Quotient Clinical Extends its Translational Pharmaceutics™ Platform
Friday, April 25, 2014
Company will employ its manufacturing capabilities to supply specialist oncology centers with drug products.

Achieving High Quality Microarray Results
Wednesday, April 23, 2014
Application note reveals superior performance of CytoSure Genomic DNA Labelling Kit.

Fluxion Biosciences Introduces IsoFlux™ NGS Assay Kits
Tuesday, April 22, 2014
New kits enable mutation detection from circulating tumor cells using next-generation sequencing.

<< 5 6 7 8 9 10 11 >>
Showing Results 71 - 80 of 2518
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv